
CBRS Stock Forecast & Price Target
CBRS Analyst Ratings
Bulls say
Cerebras Systems is viewed favorably because its wafer-scale engine technology appears to be backed by marquee relationships with OpenAI, Amazon, AMD, OCI, G42, and MBZUAI, which materially reduces skepticism about product demand and the durability of its platform. The large OpenAI commitment, including 500MW of capacity in 2027 and a $20B+ installation, provides unusually strong revenue visibility through 2027 and into 2028, while the company is also expected to beat estimates and guide slightly higher for FQ4. Even with moderation in semiconductor multiples, the company’s economics still look attractive, with annualized 500MW revenue implying just under $5B and over 50% gross margins, supporting the view that current concerns around data center spend and chip life are overstated.
Bears say
Cerebras Systems is negatively viewed because its revenue base is highly concentrated, with over 80% of past revenue tied to G42/MBZUAI and nearly all future growth depending on OpenAI, while the $25B RPO is similarly exposed and subject to warrant-related dilution and contra-revenue drag. The company also faces severe execution and capital-intensity risk: fulfilling OpenAI and AWS commitments requires rapid data-center expansion amid power-permitting and construction constraints, and management is assuming the roughly $3B IPO raise is sufficient. On top of that, Cerebras is competing against NVIDIA’s entrenched CUDA ecosystem, AMD, Intel, ASIC rivals, hyperscaler in-house chips, and a single-foundry TSMC supply chain in Taiwan, leaving limited margin for error if performance, cost, or production slips.
This aggregate rating is based on analysts' research of Cerebras Systems Inc and is not a guaranteed prediction by Public.com or investment advice.
CBRS Analyst Forecast & Price Prediction
Start investing in CBRS
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Cerebras Systems Inc (CBRS) Forecast
CBRS Analyst Forecast & Price Prediction
Start investing in CBRS
Order type
Buy in
Order amount
Est. shares
0 shares